“The Current Role of Hemostatic Agents in the Medical Management of Spontaneous Intracranial Hemorrhages”
HealthTrust presents…“The Current Role of Hemostatic Agents in the Medical Management of Spontaneous Intracranial Hemorrhages”
Please Note: Continuing education credit is only available to those attending the session live. CE credit is not available when accessing the program on demand.
Hemostatic agents remain an attractive therapeutic option for the prevention of hematoma expansion in patients presenting with spontaneous intracranial hemorrhage. Studies to date have failed to demonstrate a clear benefit on functional outcomes and mortality in patients who receive a hemostatic agent for the prevention of hematoma expansion. Current evidence suggests the benefit of hemostatic agents may be confined to specific subgroups of patients when administered in the appropriate time interval. This session will focus on the use of factor VIIa and tranexamic acid for the prevention of hematoma expansion in patients presenting with spontaneous intracranial hemorrhage. Clinical presentation, epidemiology, risk factors for intracranial hemorrhage, pathophysiology and
current guideline statements for the assessment and treatment of intracranial hemorrhage will be discussed.
Learning Objectives for Pharmacists | At the end of this session, participants should be able to:
- Assess current guidelines and identify any changes from former recommendations
- Analyze the efficacy of DOACs in HIT, as well as if any particular DOAC is preferred
- Describe patient populations that may benefit DOAC therapy in HIT, as well as patients in which DOACs may not be optimal
Gregory Taylor, Pharm D | PGY-1 Pharmacy Resident | Princeton Baptist Medical Center
Target Audience: Pharmacists & Physicians
CE Credit: Approved for Pharmacists
This program is approved for CPEs by the Accreditation Council for Pharmacy Education (ACPE). Attendees of this program may earn 1.0 CPE Contact Hours. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Universal Activity Number for this activity is 0863-9999-23-025-L01-P. The activity is approved for 1 hour (.1 CEUs) of continuing education credit for pharmacists who attend the webinar and complete the online evaluation.
Note about CE credit: If you plan to obtain credit for a live session, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit. CE credit is individual. No group credit is available. Each person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit. Attendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.